Lilly to Acquire CrossBridge Bio in $300M Deal

Read more

IQ MPS Leaders to Share Industry Progress on Advancing In Vitro NAMs Toward Regulatory Acceptance at the Investigative & Preclinical Toxicology Summit

Read more

FDA Rejects Replimune Melanoma Therapy, Citing Data Concerns

Read more

Telix and Regeneron Partner on Next-Generation Cancer Therapies

Read more

AbbVie Highlights Promising Ovarian Cancer Trial Results at SGO 2026

Read more

FDA Grants Priority Review to Lung Cancer Drug Candidate

Read more

Novo Nordisk Partners with OpenAI to Accelerate Drug Discovery

Read more

4th ADC Linker & Conjugation Summit Announces 2026 Agenda, Bringing Specialist Chemists Together in Boston This July

Read more

FDA Reviews Telix Brain Cancer Imaging Drug Application

Read more

C4 Therapeutics and Roche Expand Cancer Research Collaboration

Read more